Showing results for "Deciphera Pharmaceuticals"
markets
The Growing Popularity of Compounded Weight-Loss DrugsZach Reitano, Ro CEO, explains what is driving the growing interest for weight-loss drugs and the struggle major pharmaceutical companies are experiencing keeping up with demand. He joins David Westin on "Wall Street Week" daily. (Source: Bloomberg)May 21, 2024
industries
Nestlé Targets People on GLP-1 Drugs With Launch of Frozen PizzaNestlé SA is launching a new line of frozen foods specifically targeting users of GLP-1 drugs like Ozempic and Mounjaro, pouncing on a weight-loss drug craze that is changing eating habits and impacting industries spanning retailers to airlines.May 21, 2024
industries
Hims Debuts $199 Weight-Loss Shots, Undercutting Wegovy, OzempicIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to buy cheap, generic versions of popular drugs such as Viagra. Now it’s using that playbook to jump into the hottest part of health-care: weight-loss shots.May 20, 2024